>

Mozambique introduces lifesaving malaria vaccine into routine immunization

A critical step forward in the fight against malaria

Maputo, Mozambique, 5 August 2024

Mozambique has today introduced the lifesaving malaria vaccine into routine immunization, a critical step forward in the fight against malaria. The vaccine, known as RTS,S, is the first and only vaccine to be approved by the World Health Organization for the prevention of malaria in children.

The introduction of the vaccine into routine immunization is a major milestone in the fight against malaria. Malaria is a preventable and treatable disease, but it remains a major public health problem in Mozambique. In 2022, there were an estimated 11 million cases of malaria in Mozambique, and more than 2,000 deaths.

The RTS,S vaccine is a safe and effective way to prevent malaria. In clinical trials, the vaccine has been shown to reduce the risk of malaria by up to 40%. The vaccine is also safe, and it has been used in more than 2.5 million children in Africa.

The introduction of the RTS,S vaccine into routine immunization is a major step forward in the fight against malaria. The vaccine is expected to save lives and improve the health of children in Mozambique.